Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 497 closing their positions.
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
98% less funds holding
Funds holding: 516 → 8 (-508)
99% less call options, than puts
Call options by funds: $437K | Put options by funds: $45.7M
100% less capital invested
Capital invested by funds: $10.6B → $4.62M (-$10.6B)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 497
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.29B |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$1.21B |
| 3 |
BlackRock
New York
|
-$1.12B |
| 4 |
State Street
Boston,
Massachusetts
|
-$509M |
| 5 |
Primecap Management
Pasadena,
California
|
-$370M |
ABMD Hedge Fund Activity: Q4 2022 in Review
8 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.6B a quarter earlier.
Sellers outnumbered buyers: 497 funds closed out of ABMD and 0 opened new positions — a net loss of 497 holders — while 6 trimmed existing stakes and 1 added.
The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.
- 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 516 in Q3 2022.
- Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Abiomed Inc positions in Q4 2022 and 497 closed out, a net change of -497 holders.
- The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
- The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.
Based on aggregated 13F filings for Q4 2022.